Nomura Asset Management CO LTD Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nomura Asset Management CO LTD

20 transactions

Quarter	Operation	Price Per share	shares change
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $0 - $0	0 Closed
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $0 - $0	0 New
Q4 2021 Feb 01, 2022	BUY	$99.73 - $148.48 $0 - $0	0 New
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $0 - $0	0 New
Q2 2021 Aug 06, 2021	BUY	$65.78 - $105.02 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $0 - $0	0 New
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $0 - $0	0 New
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $0 - $0	0 New
Q4 2018 Feb 12, 2019	BUY	$29.75 - $42.9 $0 - $0	0 New
Q3 2018 Nov 07, 2018	BUY	$32.79 - $43.0 $0 - $0	0 New
Q2 2018 Aug 03, 2018	BUY	$23.62 - $42.29 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $0 - $0	0

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.6B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.